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5.1
What is the patient’s opinion of their knee? Experience from 
using the knee injury and osteroarthritis outcome score (KOOS) 
E. Roos, Sweden 
The Knee injury and Osteoarthritis Outcome Score (KOOS) is 
increasingly used for evaluation of the patient’s perspective of knee 
injury and knee osteoarthritis. The rational for and the development 
of the KOOS is outlined. Psychometric properties important for use 
in clinical trials are discussed and examples from use in cartilage 
repair, ACL reconstruction, and other interventions are given. 
Development of the KOOS 
The Knee injury and Osteoarthritis Outcome Score (KOOS) was 
developed as an extension of the WOMAC Osteoarthritis Index with 
the purpose of evaluating short-term and long-term symptoms and 
function in subjects with a variety of knee injuries possibly resulting 
JOPTUFPBSUISJUJT5IF,004IPMET¾WFTFQBSBUFMZTDPSFETVCTDBMFT
Pain, other Symptoms, Function in daily living (ADL), Function in Sport 
and Recreation (Sport/Rec), and knee-related Quality of Life (QOL).
The KOOS has been validated for several orthopaedic interventions 
such as anterior cruciate ligament reconstruction (1), meniscectomy 
(2), post-traumatic osteoarthritis (3) and total knee replacement (4). 
In addition the instrument has been used to evaluate a variety of 
other interventions including cartilage repair (5-9), tibial osteotomy 
(10, 11), physical therapy (12), nutritional supplementation (13) and 
glucosamine supplementation (14). The effect size is generally largest 
for the subscale QOL followed by the subscale Pain. The KOOS is a 
valid, reliable and responsive self-administered instrument that can 
be used for short-term and long-term follow-up of several types of 
knee injury including osteoarthritis. 
The main reason for developing a single instrument with the purpose 
of covering several types of knee injury and including osteoarthritis 
(OA), was that traumatic knee injuries often causes concomitant 
damage to multiple structures (ligaments, menisci, cartilage, etc.) 
and frequently lead to the later development of OA. To be able to 
follow patients after a trauma and to gain insight into the change 
of symptoms, function etc. over time, a questionnaire which covers 
both the short-term and long-term consequences is needed. Prior 
instruments such as the Lysholm knee scoring scale (15) have 
focused only on the short-term consequences and instruments 
such as the WOMAC Osteoarthritis Index (16) only on the long-term 
consequences. An instrument intended for follow-up of these patients 
needs to adequately monitor both the acute injury consequences in 
the physically active and younger patients, and the chronic outcome 
in the older. 
To ensure content validity for subjects with ACL injury, meniscus 
injury, and early OA, we reviewed the literature, consulted an expert 
panel, and conducted a pilot study. The literature indicated three 
principal areas of patient-relevant outcomes: symptoms, functional 
status, and satisfaction. An expert panel comprised of patients 
referred to physical therapy because of knee injuries, orthopaedic 
surgeons, and physical therapists from both Sweden and the United 
States, was asked to identify short- and long-term symptoms and 
functional disabilities resulting from a meniscus or ACL injury. Seven 
GBDUPST XFSF JEFOUJ¾FE CZ UIF QBOFM QBJO FBSMZ EJTFBTFTQFDJ¾D
TZNQUPNTMBUFEJTFBTFTQFDJ¾DTZNQUPNT	FHTZNQUPNTPG0"

function, quality of life, activity level, and satisfaction. 
A pilot study was then conducted to identify the subjectively most 
relevant factors among patients with post-traumatic osteoarthritis. 
4FWFOUZ¾WF JOEJWJEVBMT XIP IBE IBENFOJTDVT TVSHFSZ  ZFBST
previously were asked to respond to two questionnaires, both self-
administered. The participants ranged in age from 35 to 76 (mean 

 BOE TIPXFE SBEJPMPHJDBM TJHOT PG LOFF 0" EF¾OFE BT KPJOU
space narrowing and osteophytes. One of the questionnaires, by 
Flandry et al. (17), was constructed to assess symptoms of anterior 
cruciate ligament (ACL) injury and the other, WOMAC Osteoarthritis 
Index (16), for assessing symptoms of knee OA Questions that most 
frequently received high responses, and were thus considered to 
SF¿FDU UIF NPTU QSFEPNJOBOU TZNQUPNT JODMVEFE UIPTF SFMBUJOH
to pain, swelling, stiffness, and the ability to run, jump, kneel, and 
squat. 
5IF,004JTBDPNQSFIFOTJWF JOTUSVNFOU JODMVEJOH¾WFTVCTDBMFT
assessing aspects of knee injury and knee OA considered important 
by patients. Most other instruments used for acute knee injury 
aggregate items measuring different aspects into one score. This 
QSPDFEVSF ¿BUUFOT UIF SFTVMUT BOE NBLFT JOUFSQSFUBUJPO NPSF
EJG¾DVMUTJODFUIFJODMVEFEJUFNTEPOPUBMXBZTDPSSFMBUF5IF,004
JTTFMGBENJOJTUFSFEBOEUBLFTBQQSPYJNBUFMZNJOVUFTUP¾MMPVU
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It is a feasible instrument as illustrated by few missing items, 0.8% 
for subjects having knee arthroscopy and 3.2% for subjects having 
total knee replacement, when administered by mail (2, 4). Since a 
subscore can be calculated when two or less items are missing for 
each subscale, it was only in a few cases a subscore could not be 
calculated. 
KOOS in cartilage repair 
During the last two years, KOOS data is reported from several trials 
on cartilage repair (5-9). When pooling the data from these trials, 
it becomes evident that patients undergoing cartilage repair report 
worse KOOS data preoperatively compared to patients prior to ACL 
reconstruction. From a methodological perspective, having a worse 
preoperative score gives room for larger improvement. However, 
BUZFBSTBCPVUUIFTBNFEJGGFSFODFTJOUIF¾WF,004TVCTDBMFT
between groups is seen when comparing cartilage repair patients 
to patients undergoing ACL reconstruction. The different procedures 
induce about similar improvement, but the cartilage repair patients 
are worse off to start with and have a worse result at 2 years. The 
difference is most evident for the KOOS subscale Sport and Recreation 
Function, where cartilage repair patients report on average 20-30 
points worse outcomes compared to ACL reconstruction both at 
baseline and at 2 year follow-up. 
In a two year follow-up of autologous chondrocyte implantation 
	"$*
 UIF¾WFTVCTDBMFTPG UIF,004QBJOPUIFSTZNQUPNT"%-
function, Sport and Recreation Function and knee-related Quality 
of Life allows for a more detailed picture of the improvement in 
QBUJFOUTXJUIEJGGFSFOUTFWFSJUZPGEJTFBTFDPNQBSFEUPUIFNPEJ¾FE
Cincinnati Knee Score and the Lysholm Score where all items are 
aggregated into one total score (7). In patients with mild disease, 
TJHOJ¾DBOUJNQSPWFNFOUXBTPOMZTFFOJOUIF,004TVCTDBMFLOFF
related Quality of Life. This subscale holds items like “how often do 
you think of your knee” and “to what extent have you changed your 
lifestyle because of your knee” which were included into the KOOS 
after interviews with patients. This type of questions is not included 
in questionnaires where surgeons, physical therapists or other 
professionals have decided on the content of the outcome measure. 
Typically, the KOOS subscale knee-related Quality of Life is the most 
responsive subscale. 
Responsiveness and between-group differences 
The KOOS is responsive to change over time and can detect between-
group differences. The effect sizes following surgical procedures vary 
CPUIXJUISFHBSEUPUIFQSPDFEVSFCFJOHVOEFSUBLFOBOEUIFTQFDJ¾D
KOOS subscale. Generally, the subscale QOL is the most responsive, 
followed by the subscale Pain. The highest effect sizes observed are 
obtained after total knee replacement (4). 
Several randomized trials using the KOOS have been published. In a 
USJBMDPNQBSJOHUXPNFUIPETPGSFDPOTUSVDUJPOPGUIF"$-TJHOJ¾DBOU
differences between groups were found in ADL, Sport/Rec and QOL 
at various postoperative time points (18). In a trial of glucosamine 
TVQQMFNFOUBUJPO TJHOJ¾DBOU HSPVQ EJGGFSFODFT XFSF GPVOE JO
1BJOBOE"%-	
 *OBUSJBMPGBOVUSJUJPOBMTVQQMFNFOUTJHOJ¾DBOU
between-group differences were found for ADL (13). In all trials, 
TJHOJ¾DBOUJNQSPWFNFOUXBTEFUFDUFEJOUIFUSFBUNFOUHSPVQTPWFS
time. The number of subjects in each treatment arm in these RCT:
s ranged from 15 to 27. In a study on continuous passive motion 
as supplemental treatment following total knee replacement, no 
TJHOJ¾DBOUEJGGFSFODFTXFSFGPVOECFUXFFOHSPVQT	
*OBEPVCMF
blind randomized trial on recovery after arthroscopic surgery, the 
,004TIPXFETJHOJ¾DBOUEJGGFSFODFTCFUXFFOHSPVQTBMSFBEZBU
and 90 days (20). 
The minimal perceptible clinical improvement 
The minimal perceptible clinical improvement (MPCI) represents 
the difference on the measurement scale associated with the 
smallest change in the health status detectable by the patient. 
The MPCI of the KOOS has not been formally assessed. Since the 
KOOS questionnaire contains the full and original version of the 
WOMAC index and WOMAC scores can easily be calculated, the 
MPCI of approximately 10 obtained for the WOMAC (21) has been 
applied to KOOS in power analyses and when determining cut-offs 
for improvement and deterioration (22). Accordingly, a level of 10 
points or more of improvement or decline was suggested as a cut-off 
SFQSFTFOUJOHBDMJOJDBMMZTJHOJ¾DBOUEJGGFSFODF
In support of this suggestion, we compared KOOS data after ACL 
reconstruction with the clinical knowledge of rehabilitation phases 
following ACL reconstruction. Three months postoperatively, the 
patients experienced some pain, swelling and restriction in range of 
motion and had not pushed their knee during sporting activities. This 
XBTSF¿FDUFECZ	TUBUJTUJDBMMZOPOTJHOJ¾DBOU
DIBOHFTPGUP,004
score points in pain, symptoms, and sport and recreation function 
over this time interval, compared to preoperative scores. Six months 
postoperatively, the patients were back at more vigorous activities 
JODMVEJOH TQPSU BOE IBE GFX TZNQUPNT SF¿FDUFE CZ 	TUBUJTUJDBMMZ
TJHOJ¾DBOU
DIBOHFTPGTDPSFQPJOUTJOBMMTVCTDBMFTDPSFT5IVT
it seems that a change in score of 8 points or more may represent a 
DMJOJDBMMZTJHOJ¾DBOUDIBOHF GPMMPXJOH"$- SFDPOTUSVDUJPO8F UIVT
suggest that 8-10 points may represent the minimal perceptible 
clinical improvement (MPCI) of the KOOS. However, to further 
FYQMPSFUIJTEJG¾DVMURVFTUJPOBEEJUJPOBMTUVEJFTJODMVEJOHEJGGFSFOU
treatments and patient groups should be undertaken. 
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6.1
Cartilage repair rehabilitation: chondrocyte to cerebrum 
K. Hambly, United Kingdom 
Thousands of people each year experience symptoms related to 
chondral defects that often threaten quality of life, especially in an 
athletically active population (Cain & Clancy 2001; Mithoefer et al. 
2002). The treatment of articular cartilage defects has undergone a 
SBQJEBOEFYDJUJOHFWPMVUJPO JOSFDFOUZFBSTFTQFDJBMMZ JO UIF¾FME
of advanced cell-based orthobiologic technologies. New surgical 
options to repair chondral defects are now available where, 
previously, the only option has been arthroplasty (Alford & Cole 
2005).
Rehabilitation is widely considered an important component for 
successful outcome. Articular cartilage repair rehabilitation is 
MFOHUIZBOEWFSZ GFXTUVEJFTIBWFDPOTJEFSFEUIFSBNJ¾DBUJPOTPG
the lengthy rehabilitation period and its functional restrictions on 
the patient’s outcome. Whilst international research into tissue-
FOHJOFFSJOHBOETVSHJDBMUFDIOJRVFTIBTCFFO¿PVSJTIJOHSFTFBSDI
on rehabilitation remains in its infancy. A recent analysis of the 
quality of cartilage repair studies found that they are generally of low 
methodological quality (Jakobsen et al. 2005). The studies included 
in this analysis only scored a mean of 5.3 (maximum score of 10) 
in the Coleman Methodology Score for description of postoperative 
rehabilitation. This led the authors to conclude that there was a need 
to establish and report on detailed rehabilitation protocols and to 
monitor rehabilitation compliance in future studies.
Considerable variation in postoperative rehabilitative care exists 
BDSPTTDBSUJMBHFSFQBJSDFOUSFTBOEUIJTQSFTFOUTBTJHOJ¾DBOUDIBMMFOHF
to surgeons, therapists and patients alike. An initial comparative 
analysis of postoperative rehabilitation parameters for autologous 
chondrocyte implantation (ACI) at specialist cartilage repair centres 
highlighted key areas of variation in clinical practice (Hambly et al. 
2006). In particular, timescales for return to full weight bearing and 
full range of motion exhibited large variances between centres of up 
to twelve weeks in some instances. Clear patterns of variation were 
BMTPJEFOUJ¾FEJOUIFVUJMJTBUJPOPGTQFDJ¾DSFIBCJMJUBUJWFNPEBMJUJFT
in particular the extent of use of continuous passive motion (CPM) 
between the USA and the UK. Yet, despite these variations, no single 
centre to date has demonstrated the superiority of a particular 
ACI rehabilitation protocol in terms of clinical outcome measures. 
)PXFWFSUIJTNBZCFQSFEPNJOBOUMZBSF¿FDUJPOPOUIFDIPJDFBOE
validity of many of the clinical outcome measures that are in current 
use and their ability to assess functional cartilage repair outcomes.
5IF FG¾DBDZ PG DVSSFOU SFIBCJMJUBUJPO QSBDUJDF GPS DBSUJMBHF SFQBJS
surgery has yet to be established. The review of adverse events 
GPMMPXJOH"$*QVCMJTIFECZ8PPEFUBM 	
 JEFOUJ¾FEBWBSJFUZ
of adverse events as reported to the United States Food and Drug 
Administration. It is plausible, if not probable, that a reasonable 
proportion of these adverse events could be at least partially 
attributable to the rehabilitation process. Rehabilitation that is 
too aggressive or patients that return to sport too early have been 
reasons commonly proposed in the literature to explain instances 
of cartilage repair failure. However, a case could also be made 
UIBU B TJHOJ¾DBOU QSPQPSUJPOPG BEWFSTF FWFOUT GPMMPXJOH DBSUJMBHF
repair could actually be attributable to suboptimal rehabilitation via 
JOTVG¾DJFOUBQQSPQSJBUFNFDIBOJDBMTUJNVMJ/PSNBMBSUJDVMBSDBSUJMBHF
GVODUJPOSFRVJSFTNFDIBOJDBMTUJNVMJ*OTVG¾DJFOUTUJNVMJUPBSUJDVMBS
cartilage via immobilisation and partial weight bearing have been 
shown to result in a decrease in cartilage thickness and stiffness 
	)JOUFSXJNNFSFUBM&DLTUFJOFUBM
"SUISP¾CSPTJTIBT
been correlated to the duration of postoperative immobilisation and 
has been shown to become an established condition by as early as 
four weeks postoperatively (Noyes et al. 2000). This has important 
implications for the design and implementation of rehabilitation 
programmes.
Cartilage mechanobiology is complex and although there is a 
SBQJEMZ JODSFBTJOHMZ GPVOEBUJPO PG TDJFOUJ¾D JOGPSNBUJPO JO WJUSP
there is currently still a paucity of information in vivo. Knowledge 
of how cartilage repairs respond to mechanical signals under 
various exercise conditions and the level of pathological overload 
across the rehabilitative stages remains elusive. Traditionally the 
primary focus of cartilage repair rehabilitation has been on the 
protection and preservation of the local repair site. This is critical, 
but there is now an increasing recognition for the need to balance 
protection of the repair with functional rehabilitation especially in 
the latter postoperative stages. The approach to cartilage repair 
rehabilitation is evolving and there is a mounting appreciation of 
the need to approach cartilage repair rehabilitation from a more 
